Location History:
- Brunswick, AU (2005)
- Alexandria, AU (2008)
Company Filing History:
2 out of 1,333 
2 out of 525 
Years Active: 2005-2008
Title: Teresa Anne Domagala: Innovator in EGF Receptor Research
Introduction
Teresa Anne Domagala is a prominent inventor based in Alexandria, Australia. She has made significant contributions to the field of biotechnology, particularly in the development of truncated EGF receptor molecules. With a total of 2 patents, her work has the potential to impact therapeutic approaches in cancer treatment.
Latest Patents
One of her latest patents focuses on truncated EGF receptor molecules that exhibit increased binding affinities for EGFR ligands such as EGF and TGF-α. This invention not only enhances the understanding of EGF receptor interactions but also provides methods for screening EGF receptor ligands. Additionally, it outlines treatment methods that utilize these innovative molecules.
Career Highlights
Throughout her career, Teresa has worked with esteemed organizations, including the Commonwealth Scientific and Industrial Research Organisation and the Ludwig Institute for Cancer Research Limited. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific discoveries.
Collaborations
Teresa has collaborated with notable colleagues, including Colin Wesley Ward and George Oscar Lovrecz. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Teresa Anne Domagala's contributions to the field of biotechnology, particularly in EGF receptor research, highlight her role as an influential inventor. Her patents and collaborations reflect her commitment to advancing scientific knowledge and improving treatment methodologies.